Zentalis Pharmaceuticals, Inc. Restructuring Reserve, Current
Zentalis Pharmaceuticals, Inc. (ZNTL) had Restructuring Reserve, Current of $87.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Notes
us-gaap:RestructuringReserveCurrent · last filed 2025-11-10
- 2025-09-30: Restructuring Reserve, Current $87.00K.
- 2025-06-30: Restructuring Reserve, Current $543.00K.
- 2025-03-31: Restructuring Reserve, Current $4.41M.
- 2024-12-31: Restructuring Reserve, Current $0.00.
| Period end | Restructuring Reserve, Current |
|---|---|
| 2025-09-30 | $87.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $543.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $4.41M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |